Background: Accurate prediction of 28-day mortality in intensive care unit (ICU) patients represents a critical challenge in modern critical care medicine, with profound implications for clinical decision-making, resource optimization, and patient-centered care. Traditional severity scoring systems and conventional machine learning approaches have consistently demonstrated limitations in discriminative performance, calibration accuracy, and generalizability across heterogeneous patient populations. Methods: This retrospective cohort study employed comprehensive data from 654 consecutively admitted adult ICU patients at a tertiary academic medical center between August 2022 and August 2024.We developed and rigorously validated four distinct prediction methodologies: Logistic Regression (LR), Random Forest (RF), Gradient Boosting (GB), and an innovative Multi-Model Fusion (MMF) framework incorporating probability averaging from constituent models. Our evaluation framework encompassed exhaustive discrimination metrics (AUC-ROC, sensitivity, specificity, F1-score), sophisticated calibration assessment (Brier score, calibration curves, Hosmer-Lemeshow test), detailed subgroup analyses across clinically relevantpatient strata, and multi-dimensional feature importance evaluation. Results: The Multi-Model Fusion paradigm demonstrated statistically superior performance with an AUC-ROC of 0.862 (95% CI: 0.821-0.903), significantly outperforming all individual models (LR: ΔAUC=0.121, p0.7, 83.3%). Conclusion: The Multi-Model Fusion framework establishes a clinically actionable and methodologically sophisticated paradigm for 28-day mortality prediction in ICU patients, effectively addressing fundamental limitations of conventional approaches through enhanced discriminative performance, exemplary calibration accuracy, and consistent generalizability across diverse patient populations. These compelling findings strongly advocate for its integration intoICU clinical decision support ecosystems to advance prognostic precision and guide personalized therapeutic strategies.
Zhanzhi Long (Tue,) studied this question.